First Manhattan’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3
| Closed | -$219 | – | 1391 |
|
|
2024
Q1 | $219 | Hold |
3
| – | – | ﹤0.01% | 1375 |
|
|
2023
Q4 | $517 | Hold |
3
| – | – | ﹤0.01% | 1362 |
|
|
2023
Q3 | $2.06K | Hold |
3
| – | – | ﹤0.01% | 1312 |
|
|
2023
Q2 | $13.4K | Hold |
3
| – | – | ﹤0.01% | 1090 |
|
|
2023
Q1 | $7.72K | Sell |
3
-1
| -25% | -$2.58K | ﹤0.01% | 1242 |
|
|
2022
Q4 | $9.62K | Hold |
4
| – | – | ﹤0.01% | 1255 |
|
|
2022
Q3 | $14K | Sell |
4
-3
| -43% | -$10.5K | ﹤0.01% | 1155 |
|
|
2022
Q2 | $16K | Buy |
7
+1
| +17% | +$2.29K | ﹤0.01% | 1157 |
|
|
2022
Q1 | $18K | Hold |
6
| – | – | ﹤0.01% | 1184 |
|
|
2021
Q4 | $35K | Hold |
6
| – | – | ﹤0.01% | 1066 |
|
|
2021
Q3 | $52K | Hold |
6
| – | – | ﹤0.01% | 987 |
|
|
2021
Q2 | $57K | Buy |
6
+3
| +100% | +$28.5K | ﹤0.01% | 957 |
|
|
2021
Q1 | $60K | Buy |
+3
| New | +$60K | ﹤0.01% | 927 |
|